· Intro
· Nervous
· CVS
· Resp
· Other
Dose |
· 20mg/mL x 20mL = 400mg = 5.7mg/kg (exceeds toxic subcut dose) |
Effects |
· CSF effects >> systemic effects · Blockade of lumbar cord -> thoracic -> cervical -> brainstem |
Time course |
· Total spinal within ~10 mins · Duration ~ 2 hours (shorter than many operations) |
Lower body |
· Sensory and motor loss · Muscle relaxation facilitates surgical access |
Upper body Head and neck |
· Sensory > motor loss |
Cranial nerves |
· CNX (pharynx and larynx for intubation) · CNIII EW (mydriasis) |
Medulla |
· Block ascending reticular activating system -> coma |
Delayed complications |
· Risk of transient neurological symptoms o Buttock and thigh pain without neuro deficit) |
Lumbar and low thoracic level |
· Venodilatation -> ↓preload (exacerbated by hypovolaemia) · Vasodilatation -> ↓SVR · ↓mAP · Reflex ↑HR may be significant (baroreceptor response) |
High thoracic and cervical level |
· ↓HR and ↓contractility (acceleromotor T1-4) · ↓↓mAP · Absent baroreceptor response |
Brainstem level |
· Zero SNS output (RVLM), zero PSNS output (dorsal motor nucleus and nucleus ambiguus) · ↓↓mAP · HR at intrinsic SA node rate 110bpm, absent baroreceptor response (this is from first principles – I have no evidence for it) |
Thoracic level |
· Intercostal paralysis |
Upper cervical level |
· C3-5: diaphragm paralysis · (Note phrenic nerve is large and resistant to blockade) |
Brainstem level |
· CNIX, X: ↓↓airway reflexes, glottic opening, risk aspiration if unprotected · CNIII: dilated pupils · Medulla: paralysed resp centre, apnoea |
Musculoskeletal |
· ↓↓Muscle tone -> improved surgical access |
GIT |
· ↓PSNS output -> ↓GIT activity |
Temp |
· Vasodilatation, venodilatation, -> peripheral heat distribution -> ↑↑heat loss |
Systemic effect |
· Risk of CVS toxicity: conduction delay, re-entrant tachyarrhythmias, arrest |
Feedback welcome at ketaminenightmares@gmail.com